System, Test, Fibrin/Fibrinogen Degradation Products For Monitoring Of Colorectal Cancer
The Fibrin/Fibrinogen Degradation Products Test System for Colorectal Cancer Monitoring is a diagnostic device used to monitor colorectal cancer patients after therapy for disease progression, used in conjunction with other diagnostic modalities. It measures fibrin and fibrinogen degradation products as tumor-associated markers in the oncology setting. It is an FDA Class 2 device regulated under 21 CFR 866.6010 in the Immunology specialty, with product code NTY, requiring 510(k) clearance. Third-party review is available. It is not an implant and does not carry life-sustaining support designation.
Research product code NTY in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- NTY
- Device Class
- FDA class 2
- Regulation Number
- 866.6010
- Medical Specialty
- Immunology
- Review Panel
- IM
- Submission Type
- 1
Device Characteristics
Definition
MONITORING CANCER PATIENTS AFTER THERAPY FOR DISEASE PROGRESSION IN CONJUNCTION WITH OTHER DIAGNOSTIC MODALITIES.
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K072901 | AMDL-ELISA DR-70 (FDP) IMMUNOASSAY, MODEL DR2101 | Jul 01, 2008 | Substantially Equivalent | Amdl, Inc. |